In our study, we conducted an analysis of the survival of breast cancer patients based on the expression of PAX7, revealing that elevated levels of PAX7 were linked to unfavourable outcomes in terms of disease‐specific survival (DSS) and progression‐free interval (PFI). The gene discussed is PAX7; the disease is breast carcinoma.